1/26/2012 – “Amgen, Celgene, Roche Deals Signal M&A Frenzy for Drug Companies” by Brett Chase of Minyanville
1/5/2012 – “Dendreon reports spike in Provenge sales; shares soar” by Bill Berkrot of Reuters
10/11/2011 – “Nobel prize-winning science should incubate deals” by David Holley of The Deal
10/7/2011 – “Zytiga creeps up on Provenge prostate-cancer drug” by Ransdell Pierson of Reuters
8/23/2011 – “What’s a Cancer Drug Worth?” by Brett Chase of Minyanville
8/22/2011 – “With Dendreon Humbled, Lessons Learned For Cancer Vaccine Makers” by Emily Hayes of The Pink Sheet
8/17/2011 – “Daiichi Sankyo is poster company for sector ripe for M&A” by David Holley of The Deal Pipeline
8/4/2011 – “Dendreon plunges as Provenge prospects wither” by by Bill Berkrot of Reuters
8/4/2011 – “Dendreon’s Stock Plunges on Low Provenge Sales” by Brett Chase of Minyanville
